Phasebio Pharmaceuticals Inc (PHAS)

Hedge Fund Popularity

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Avidity Partners Management

David Witzke And Michael Gregory

4,405,000 $5,815 0.12%
2.
RA Capital Management

Peter Kolchinsky

2,850,000 $3,762 0.08%
3.
Rock Springs Capital Management

Kris Jenner, Gordon Bussard, Graham Mcphail

2,613,825 $3,450 +2% 0.08%
4. 378,611 $500 0.13%
5.
Endurant Capital Management

Vishal Saluja And Pham Quang

243,795 $322 -33% 0.08%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$3.08 3,000 Director 4,000 2021-08-18 Filing
$3.08 3,000 Director 4,000 2021-08-18 Filing
$3.00 10,000 Director 32,943 2021-08-18 Filing
$4.12 6,000 Director 6,000 2020-12-03 Filing
$3.50 2,000 Director 22,943 2020-11-24 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$0.79 11,248 Officer 0 2022-05-23 Filing
$2.37 5,766 Officer 0 2021-11-19 Filing
$3.29 3,811 Officer 0 2021-05-20 Filing
$3.45 3,497 Officer 0 2020-11-23 Filing
$14.00 459 Large Shareholder, Director 415,959 2019-07-01 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 6,643,702 $8,770 0.25%
2. 1,826,131 $2,410 0%
3. 1,674,690 $2,210 0%
4. 1,607,044 $2,121 0.4%
5. 1,418,279 $1,872 0.03%
News See All